US pharmaceutical company Pfizer is refusing to provide information about an agreement to newly regulate a controversial, multibillion-dollar EU vaccine purchase from 2021. Instead of responding to questions from MPs on the COVI special committee looking into the Covid-19 crisis, the company sent a list of questions and refused to allow access to files. According to the Parliament, this is unacceptable.
Continue reading now
… and get free access to this Professional Briefing for a month.
Are you already a guest at the Europe.Table? Log in now